ZENG, DEWAN,BLACKBURN, MICHAEL R,BELARDINELLI, LUIZ
申请号：
NZ58965705
公开号：
NZ589657A
申请日:
2005.10.14
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
The disclosure relates to the use of the A2B receptor antagonist 3-ethyl-l-propyl-8-{ 1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl} -1 ,3,7 -trihydropurine-2,6-dione for the preparation of a pharmaceutical composition for the treatment of COPD in a mammal, as well as for the treatment of pulmonary fibrosis.
